SCHEMBL8976338

SCHEMBL8976338

CC(=Cc1ccccc1)CN1CCN(Cc2ccc(O)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.62
USP2 O75604 1/20 0.62
ALOX15 P16050 1/20 0.62
TSHR P16473 1/20 0.62
TDP1 Q9NUW8 3/20 0.55
ALDH1A1 P00352 3/20 0.55
DRD4 P21917 1/20 0.55
KDM4E B2RXH2 3/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
MAPT P10636 4/20 0.52
MAPK1 P28482 3/20 0.52
LMNA P02545 3/20 0.52
GAA P10253 1/20 0.51
POLB P06746 2/20 0.47
THRB P10828 1/20 0.47
HPGD P15428 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2C P18825 1/20 0.46
SLC6A4 P31645 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8976331 1.00 SMN1; SMN2 (0.62) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL8976340 0.91 SMN1; SMN2 (0.68) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL8976337 0.91 SMN1; SMN2 (0.68) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL8976303 0.89 SMN1; SMN2 (0.62) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL8976310 0.89 SMN1; SMN2 (0.62) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL8976616 0.85 SIGMAR1 (0.65) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL8976614 0.85 SIGMAR1 (0.65) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL13539640 0.79 TSHR (0.72) SMN1; SMN2USP2ALOX15TSHRTDP1
SCHEMBL8976376 0.79 MEN1 (0.67) SMN1; SMN2ALOX15ALDH1A1MEN1KMT2A
SCHEMBL8976380 0.79 MEN1 (0.67) SMN1; SMN2ALOX15ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1053441-C Compound with 1-(aryl Chain olefine)-4-(aryl methyl) piperazine structure, preparation process thereof and medicine thereof ADIR ET CO (FR) 2000-06-14 CN disclosed
EP-0707004-A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them ADIR ET COMPAGNIE (FR) 1996-04-17 EP disclosed